- All sections
- C - Chemistry; metallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 279/04 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
Patent holdings for IPC class C07C 279/04
Total number of patents in this class: 77
10-year publication summary
8
|
12
|
9
|
8
|
3
|
5
|
6
|
3
|
0
|
1
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immunomet Therapeutics Inc. | 30 |
6 |
Monsanto Technology LLC | 7905 |
4 |
Emory University | 1498 |
4 |
BASF SE | 19740 |
3 |
Ramot at Tel-Aviv University Ltd. | 1370 |
3 |
Sika Technology AG | 2650 |
3 |
3m Innovative Properties Company | 18406 |
2 |
Flamel Technologies | 49 |
2 |
King Abdulaziz University | 511 |
2 |
Lantheus Medical Imaging, Inc. | 174 |
2 |
The Penn State Research Foundation | 1423 |
2 |
Philipps-universitat Marburg | 111 |
2 |
San-Apro Limited | 73 |
2 |
Sanford-Burnham Medical Research Institute | 128 |
2 |
Waters Technologies Corporation | 1654 |
2 |
Murata Manufacturing Co., Ltd. | 22355 |
1 |
The Regents of the University of Michigan | 4409 |
1 |
The Johns Hopkins University | 5377 |
1 |
The General Hospital Corporation | 4517 |
1 |
Tsinghua University | 5426 |
1 |
Other owners | 31 |